On the Record · Quidel

Quidel acquisitions, on the record

The businesses Quidel bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

Business	Deal	When	Value
Triage Business and BNP Business (Triage® MeterPro® Cardiovascular and toxicology business and BNP assay business run on Beckman Coulter analyzers) from Alere Inc. Word for word“On October 6, 2017, we closed our acquisition of the Triage ® MeterPro ® Cardiovascular (CV) and toxicology business (“Triage Business”), and B-type Naturietic Peptide (BNP) assay business run on Beckman Coulter analyzers (“BNP Business” and, together, the “Triage and BNP Businesses”) from Alere Inc. (“Alere”).” 10-K for 2019	acquisition	On October 6, 2017	—
Summers Ridge property Word for word“Our investing activities provided $115.0 million during the year ended December 31, 2018 primarily from the sale of the Summers Ridge property for $146.6 million .” 10-K for 2019	divestiture	2018	$146.6 million
Triage Business (Triage MeterPro Cardiovascular and toxicology business) from Alere Inc. Word for word“In 2017, we acquired the Triage ® MeterPro ® Cardiovascular (CV) and toxicology business (“Triage Business”), and B-type Naturietic Peptide (BNP) assay business run on Beckman Coulter analyzers (“BNP Business” and, together, the “Triage and BNP Businesses”) from Alere Inc. (“Alere”), which added an extensive cardiovascular and toxicology menu to our innovative medical diagnostics portfolio.” 10-K for 2020	acquisition	2017	—
Triage and BNP Businesses from Alere Word for word“On October 6, 2017, we acquired the Triage and BNP Businesses from Alere.” 10-K for 2020	acquisition	On October 6, 2017	—
BioHelix Corporation Word for word“Before joining Quidel, Dr. Ranalli was the Director of Business Development at BioHelix Corporation where she was instrumental in both the development of the novel isothermal technology used in the Solana platform as well as in establishing the collaboration between BioHelix and Quidel that led to our eventual acquisition of BioHelix in 2013.” 10-K for 2020	acquisition	2013	—
Ortho Word for word“Ortho will be acquired for total consideration of approximately $4.3 billion (which is based on the February 9, 2022 closing price of $97.64 per Quidel Share), including $1.75 billion of cash, funded through cash on our balance sheet and expected incremental borrowings.” 10-K for 2021	agreed acquisition	—	approximately $4.3 billion
BNP Business (transition to Beckman Coulter, Inc.) Word for word“On July 24, 2021, we entered into agreements with Beckman to transition the BNP Business to Beckman.” 10-K for 2021	agreed divestiture	July 24, 2021	—

As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year ended	Cash paid for acquisitions (net of cash acquired)
2016-12-31	$5.1 million
2017-12-31	$14.5 million
2018-12-31	$0
2019-12-31	$0

Deal filings since 2016

2021-12-23 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2021-07-26 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2021-05-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-11-13 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-09-17 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-09-04 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-01-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-01-09 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2017-10-06 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-10-06 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2017-09-18 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-07-17 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2016-03-30 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement

Read from Quidel’s annual reports (10-K for 2021, 10-K for 2020, 10-K for 2019) and the financial data it files with the SEC, as of 2022-02-18. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.